JP Morgan Chase’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $883K | Sell |
98,495
-11,595
| -11% | -$97.2K | ﹤0.01% | 4685 |
|
|
2025
Q4 | $819K | Sell |
110,090
-4,687
| -4% | -$33.7K | ﹤0.01% | 4732 |
|
|
2025
Q3 | $768K | Sell |
114,777
-128,933
| -53% | -$895K | ﹤0.01% | 4770 |
|
|
2025
Q2 | $1.61M | Sell |
243,710
-39,433
| -14% | -$280K | ﹤0.01% | 4071 |
|
|
2025
Q1 | $2.59M | Sell |
283,143
-15,987
| -5% | -$160K | ﹤0.01% | 3676 |
|
|
2024
Q4 | $3.14M | Buy |
299,130
+45,390
| +18% | +$537K | ﹤0.01% | 3802 |
|
|
2024
Q3 | $3.03M | Buy |
253,740
+176,442
| +228% | +$1.53M | ﹤0.01% | 3633 |
|
|
2024
Q2 | $444K | Sell |
77,298
-29,208
| -27% | -$160K | ﹤0.01% | 4750 |
|
|
2024
Q1 | $554K | Buy |
106,506
+49,697
| +87% | +$243K | ﹤0.01% | 4734 |
|
|
2023
Q4 | $299K | Buy |
56,809
+56,534
| +20,558% | +$224K | ﹤0.01% | 5108 |
|
|
2023
Q3 | $908 | Sell |
275
-1,504
| -85% | -$5.28K | ﹤0.01% | 6659 |
|
|
2023
Q2 | $5.14K | Sell |
1,779
-104,479
| -98% | -$201K | ﹤0.01% | 6167 |
|
|
2023
Q1 | $114K | Sell |
106,258
-235,442
| -69% | -$450K | ﹤0.01% | 5366 |
|
|
2022
Q4 | $892K | Sell |
341,700
-10,728
| -3% | -$46.8K | ﹤0.01% | 4131 |
|
|
2022
Q3 | $2.47M | Sell |
352,428
-9,355
| -3% | -$73.3K | ﹤0.01% | 3305 |
|
|
2022
Q2 | $2.47M | Sell |
361,783
-852
| -0.2% | -$8.69K | ﹤0.01% | 3371 |
|
|
2022
Q1 | $5.11M | Sell |
362,635
-40,458
| -10% | -$542K | ﹤0.01% | 2984 |
|
|
2021
Q4 | $5.84M | Buy |
403,093
+35,617
| +10% | +$506K | ﹤0.01% | 2932 |
|
|
2021
Q3 | $5.2M | Sell |
367,476
-16,976
| -4% | -$261K | ﹤0.01% | 2994 |
|
|
2021
Q2 | $6.77M | Buy |
384,452
+362,855
| +1,680% | +$5.85M | ﹤0.01% | 2779 |
|
|
2021
Q1 | $330K | Buy |
+21,597
| New | +$308K | ﹤0.01% | 4916 |
|
Other funds holding BVS
EWM
JIC
NCM
VCM
RA
VPM
